MediciNova develops and commercializes small molecule therapeutics. The company has built a portfolio of drug candidates by co-researching with Japanese pharmaceutical companies. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.